118
- Iwaguro H, Yamaguchi J, Kalka C, Murasawa S, Masuda H, Hayashi S, et al. Endothelial
progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration.
Circulation. 2002;105:732–8. - Brunt KR, Wu J, Chen Z, Poeckel D, Dercho RA, Melo LG, et al. Ex vivo Akt/HO-1 gene
therapy to human endothelial progenitor cells enhances myocardial infarction recovery. Cell
Transplant. 2012;21:1443–61. - Kaur S, Kumar TR, Uruno A, Sugawara A, Jayakumar K, Kartha CC. Genetic engineering
with endothelial nitric oxide synthase improves functional properties of endothelial progenitor
cells from patients with coronary artery disease: an in vitro study. Basic Res Cardiol.
2009;104:39–749. - Kaur S, Harikrishnan VS, Radhakrishnan S, Uruno A, Sugawara A, et al. Transfection of
endothelial nitric oxide synthase gene improves angiogenic efficacy of endothelial progenitor
cells in rabbits with hindlimb ischemia. J Clin Exp Cardiol. 2011;2:140. doi:10.4172/
2155-9880.1000140. - Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S,
Korte T, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction:
the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–8. - Assmus B, et al. Transcoronary transplantation of progenitor cells after myocardial infarction.
N Engl J Med. 2006;355(12):1222–32. - Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, et al. Stem cell treatment
for acute myocardial infarction. Cochrane Database Syst Rev. 2012;2:Cd006536. - Fisher SA, Brunskill SJ, Doree C, Mathur A, Taggart DP, Martin-Rendon E. Stem cell therapy
for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst Rev.
2014;4:CD007888. - Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, et al. Differentiation
of human embryonic stem cells into embryoid bodies comprising the three embryonic germ
layers. Mol Med. 2000;6:88–95. - Boheler KR, Czyz J, Tweedie D, Yang HT, Anisimov SV, Wobus AM. Differentiation of plu-
ripotent embryonic stem cells into cardiomyocytes. Circ Res. 2002;91:189–201. - Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, et al.
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance
function of infarcted rat hearts. Nat Biotechnol. 2007;25:1015–24. - Min JY, Huang X, Xiang M, Meissner A, Chen Y, Ke Q, et al. Homing of intravenously infused
embryonic stem cell-derived cells to injured hearts after myocardial infarction. J Thorac
Cardiovasc Surg. 2006;131:889–97. - Kehat I, Khimovich L, Caspi O, Gepstein A, Shofti R, Arbel G, et al. Electromechanical
integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol.
2004;22:1282–9. - Chong JJ, Murry CE. Cardiac regeneration using pluripotent stem cells—progression to large
animal models. Stem Cell Res. 2014;13:654–65. - Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, et al.
Generation of functional murine cardiac myocytes from induced pluripotent stem cells.
Circulation. 2008;118:507–17. - Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, et al. Directed and system-
atic differentiation of cardiovascular cells from mouse induced pluripotent stem cells.
Circulation. 2008;118:498–506. - Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T, et al. Feasibility, safety,
and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets
in a porcine ischemic cardiomyopathy model. Circulation. 2012;126:S29–37. - Miki K, Uenaka H, Saito A, Miyagawa S, Sakaguchi T, Higuchi T, et al. Bioengineered myo-
cardium derived from induced pluripotent stem cells improves cardiac function and attenuates
cardiac remodeling following chronic myocardial infarction in rats. Stem Cells Transl Med.
2012;1:430–7.
S. Kaur et al.